The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder

1994, 715 Johnson, 1987, The epidemiology and social impact of premenstrual symptoms, Clin Obstet Gynecol, 30, 367, 10.1097/00003081-198706000-00017 Rivera-Tovar, 1990, Late luteal phase dysphoric disorder in young women, Am J Psychiatry, 147, 1634, 10.1176/ajp.147.12.1634 Ramcharan, 1992, The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors, J Clin Epidemiol, 45, 377, 10.1016/0895-4356(92)90039-P Eriksson, 1995, The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome, Neuropsychopharmacol, 12, 167, 10.1038/sj.npp.1380251 Eriksson, 1990, Effect of clomipramine on premenstrual syndrome, Acta Psychiatr Scand, 81, 87, 10.1111/j.1600-0447.1990.tb06455.x Pearlstein, 1997, Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder, J Clin Psychopharmacol, 17, 261, 10.1097/00004714-199708000-00004 Sundblad, 1992, Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial, Acta Psychiatr Scand, 85, 39, 10.1111/j.1600-0447.1992.tb01440.x Yonkers, 1996, Paroxetine as a treatment for premenstrual dysphoric disorder, J Clin Psychopharmacol, 16, 3, 10.1097/00004714-199602000-00002 Su, 1997, Fluoxetine in the treatment of premenstrual dysphoria, Neuropsychopharmacol, 16, 346, 10.1016/S0893-133X(96)00245-X Yonkers, 1997, Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: a randomized controlled trial (Sertraline Premenstrual Dysphoric Collaborative Study Group), JAMA, 278, 983, 10.1001/jama.1997.03550120043031 Steiner, 1995, Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group, N Engl J Med, 332, 1529, 10.1056/NEJM199506083322301 Steiner, 1999, The measurement of premenstrual mood symptoms, J Affect Disord, 53, 269, 10.1016/S0165-0327(98)00121-9 Rubinow, 1984, Prospective assessment of menstrually related mood disorders, Am J Psychiatry, 141, 684, 10.1176/ajp.141.5.684 McCormack, 1988, Clinical applications of visual analogue scales: a critical review, Psychol Med, 18, 1007, 10.1017/S0033291700009934 Casper, 1986, Premenstrual syndrome: documentation by a linear analog scale compared with two descriptive scales, Am J Obstet Gynecol, 155, 862, 10.1016/S0002-9378(86)80040-0 Steiner, 1980, Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales, Acta Psychiatr Scand, 62, 177, 10.1111/j.1600-0447.1980.tb00605.x Menkes, 1993, Fluoxetine's spectrum of action in premenstrual syndrome, Int Clin Psychopharmacol, 8, 95, 10.1097/00004850-199300820-00003 Wood, 1992, Treatment of premenstrual syndrome with fluoxetine: a double- blind, placebo-controlled, crossover study, Obstet Gynecol, 80, 339 Ozeren, 1997, Fluoxetine in the treatment of premenstrual syndrome, Eur J Obstet Gynecol Reprod Biol, 73, 167, 10.1016/S0301-2115(97)02741-3 Mortola, 1990, Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences, Obstet Gynecol, 76, 302 Wikander, 1998, Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?, J Clin Psychopharmacol, 18, 390, 10.1097/00004714-199810000-00007 Sundblad, 1993, Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial, Neuropsychopharmacol, 9, 133, 10.1038/npp.1993.52 Rapkin, 1992, The role of serotonin in premenstrual syndrome, Clin Obstet Gynecol, 35, 629, 10.1097/00003081-199209000-00022 Ashby, 1988, Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome, Biol Psychiatry, 24, 225, 10.1016/0006-3223(88)90277-6 Parry, 1987, Therapeutic effect of sleep deprivation in patients with premenstrual syndrome, Am J Psychiatry, 144, 808, 10.1176/ajp.144.6.808 Parry, 1989, Morning versus evening bright light treatment of late luteal phase dysphoric disorder, Am J Psychiatry, 146, 1215, 10.1176/ajp.146.9.1215 Monteleone, 2000, Allopregnanolone concentrations and premenstrual syndrome, Eur J Endocrinol, 142, 269, 10.1530/eje.0.1420269 Rapkin, 1997, Progesterone metabolite allopregnanolone in women with premenstrual syndrome, Obstet Gynecol, 90, 709, 10.1016/S0029-7844(97)00417-1 Paul, 1992, Neuroactive steroids, FASEB J, 6, 2311, 10.1096/fasebj.6.6.1347506 Brot, 1997, The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors, Eur J Pharmacol, 325, 1, 10.1016/S0014-2999(97)00096-4 Uzunov, 1996, Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography, Proc Natl Acad Sci U S A, 93, 12599, 10.1073/pnas.93.22.12599 Sumner, 1995, Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat, J Steroid Biochem Mol Biol, 54, 15, 10.1016/0960-0760(95)00075-B